BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14261185)

  • 1. DRUG RESISTANCE IN PULMONARY TUBERCULOSIS; TREATMENT WITH ETHIONAMIDE IN VARIOUS DRUG COMBINATIONS.
    MEDINA G; CHAPMAN PT
    Dis Chest; 1965 Feb; 47():146-52. PubMed ID: 14261185
    [No Abstract]   [Full Text] [Related]  

  • 2. THE USE OF ETHIONAMIDE IN COMBINED DRUG REGIMENS IN THE RE-TREATMENT OF ISONIAZID-RESISTANT PULMONARY TUBERCULOSIS.
    SCHLESS JM; ALLISON RF; INGLIS RM; WHITE EF; TOPPERMAN S
    Am Rev Respir Dis; 1965 May; 91():728-37. PubMed ID: 14280946
    [No Abstract]   [Full Text] [Related]  

  • 3. [ETHIONAMIDE IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
    ZIERSKI M
    G Ital Chemioter; 1963; 10():110-7. PubMed ID: 14074246
    [No Abstract]   [Full Text] [Related]  

  • 4. RE-TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS AT BATTEY STATE HOSPITAL.
    CORPE RF; BLALOCK FA; GROSS JH; GOLDHAMMER EJ
    Am Rev Respir Dis; 1964 Dec; 90():957-60. PubMed ID: 14233802
    [No Abstract]   [Full Text] [Related]  

  • 5. [THE TREATMENT OF TUBERCULOSIS WITH 2ND LINE DRUGS].
    SCHWARTZ WS
    Sem Med; 1964 Mar; 124():523-34. PubMed ID: 14156390
    [No Abstract]   [Full Text] [Related]  

  • 6. [ANTIMICROBIAL TREATMENT OF TUBERCULOSIS WITH SUBSIDIARY DRUGS. 2ND LINE DRUGS].
    ACEVEDO RC; HERRERO JJ; PILHEU J; RODRIGUEZ E
    Sem Med; 1964 Mar; 124():534-43. PubMed ID: 14156391
    [No Abstract]   [Full Text] [Related]  

  • 7. CHEMOTHERAPY REGIMENS USED IN RETREATMENT OF PULMONARY TUBERCULOSIS. II. OBSERVATIONS ON THE EFFICACY OF COMBINATIONS OF ETHAMBUTOL, CAPREOMYCIN AND COMPANION DRUGS, INCLUDING 4-4 DIISOAMYLOXYTHIOSEMICARBANILIDE.
    KASS I
    Tubercle; 1965 Jun; 46():166-77. PubMed ID: 14327964
    [No Abstract]   [Full Text] [Related]  

  • 8. PULMONARY TUBERCULOSIS.
    CHAVES AD
    Mod Treat; 1964 Mar; 1():330-59. PubMed ID: 14159591
    [No Abstract]   [Full Text] [Related]  

  • 9. SPUTUM CONVERSION IN CHRONIC TUBERCULOSIS WITH POLYRESISTANT BACILLI.
    NOVAK M; JANCIK E
    Acta Tuberc Pneumol Scand; 1964; 45():301-19. PubMed ID: 14234473
    [No Abstract]   [Full Text] [Related]  

  • 10. [THERAPEUTIC PLAN].
    DUBRA F
    Torax; 1963; 12():147-8. PubMed ID: 14159778
    [No Abstract]   [Full Text] [Related]  

  • 11. CHEMOTHERAPY REGIMENS USED IN RETREATMENT OF PULMONARY TUBERCULOSIS. I. OBSERVATIONS ON THE EFFICACY OF COMBINATIONS OF KANAMYCIN, ETHIONAMIDE AND EITHER CYCLOSERINE OR PYRAZINAMIDE.
    KASS I
    Tubercle; 1965 Jun; 46():151-65. PubMed ID: 14327963
    [No Abstract]   [Full Text] [Related]  

  • 12. [THE USE OF ANTIBACILLARY DRUGS].
    BERNARD E; PIERON R
    Cah Coll Med Hop Paris; 1964 Apr; 5():241-51. PubMed ID: 14146836
    [No Abstract]   [Full Text] [Related]  

  • 13. CHEMOTHERAPY FOR PATIENTS WITH CULTURES RESISTANT TO STREPTOMYCIN, ISONIAZID AND PAS.
    JANCIK E; ZELENKA M; TOUSEK J; MAKOVA M
    Tubercle; 1963 Dec; 44():443-5. PubMed ID: 14101324
    [No Abstract]   [Full Text] [Related]  

  • 14. MODERN DRUG TREATMENT OF MYCOBACTERIAL DISEASES.
    WOLINSKY E
    Med Clin North Am; 1963 Sep; 47():1271-83. PubMed ID: 14062093
    [No Abstract]   [Full Text] [Related]  

  • 15. SOME PROBLEMS IN THE MANAGEMENT OF TUBERCULOSIS.
    MITCHELL JH
    Br J Clin Pract; 1964 Feb; 18():63-8. PubMed ID: 14115576
    [No Abstract]   [Full Text] [Related]  

  • 16. [Various biological tests on several groups of subjects with tuberculosis subjected respectively to monotherapy with isoniazid, viomycin, pyrazinamide, cycloserine, ethioniamide and kanamycin].
    DE SIMONI G; CATTANEO C
    Ann Ist Carlo Forlanini; 1962; 22():326-65. PubMed ID: 14026068
    [No Abstract]   [Full Text] [Related]  

  • 17. [NEW DRUGS IN THE TREATMENT OF PULMONARY TUBERCULOSIS].
    LESTON JM
    Sem Med; 1964 Apr; 124():855-60. PubMed ID: 14181019
    [No Abstract]   [Full Text] [Related]  

  • 18. The tate of patients with drug-resistant tubercle bacilli and pulmonary tuberculosis.
    PINES A
    Br J Dis Chest; 1962 Oct; 56():163-70. PubMed ID: 13943667
    [No Abstract]   [Full Text] [Related]  

  • 19. CHEMOTHERAPY OF TUBERCULOSIS.
    HORNE NW
    Biochem Clin; 1964; 4():207-15. PubMed ID: 14268921
    [No Abstract]   [Full Text] [Related]  

  • 20. SIDE EFFECTS OF AN ANTITUBERCULOUS FIVE-DRUG REGIMEN: ETHIONAMIDE, CYCLOSERINE, PYRAZINAMIDE, VIOMYCIN AND ISONIAZID.
    TANI P; POPPIUS H
    Acta Tuberc Pneumol Scand; 1963; 43():256-64. PubMed ID: 14072347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.